NCBI Home Page NCBI Site Search page NCBI Guide that lists and describes the NCBI resources
Conserved domains on  [gi|2183801873|ref|WP_235956006|]
View 

phosphotransferase [Rouxiella aceris]

Protein Classification

Graphical summary

 Zoom to residue level

show extra options »

Show site features     Horizontal zoom: ×

List of domain hits

Name Accession Description Interval E-value
PRK06148 super family cl32120
hypothetical protein; Provisional
11-344 4.32e-89

hypothetical protein; Provisional


The actual alignment was detected with superfamily member PRK06148:

Pssm-ID: 180426 [Multi-domain]  Cd Length: 1013  Bit Score: 288.08  E-value: 4.32e-89
                           10        20        30        40        50        60        70        80
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2183801873   11 LTSDAPQVSLPQVQQIAAELYGLQGTPSGLAGERDSNFRLLTANNQGYMLRFINAAEQPAEMAFQSAMLAHIARQDSTLP 90
Cdd:PRK06148     4 LSHPAPEFTTKDAEALLAQHFGISATATPLDGERDLNFRLTTDDGADYILKIVNPSEPRVESDFQTAALDHLAAVAPDLP 83
                           90       100       110       120       130       140       150       160
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2183801873   91 VPRVVTSLQGETTP--HYPMGEQRLtLRMVTYLPGTPQV-MMPRTTALMRNLGDTLARLDLALSNFAHPGADRSLLWNLS 167
Cdd:PRK06148    84 VPRLIPSLSGASLAsaQDPDGEPRL-LRLLSWLPGTPLAeAAPRTEALLDNLGRALGRLDRALQGFMHPGALRDLDWDLR 162
                          170       180       190       200       210       220       230       240
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2183801873  168 EMPQMASWIAHLADPAQREAVATVLARYQQDVAPQLSQLRRQVIHNDLNPHNVLVTAE--HQVAGIIDFGDALQAPLINE 245
Cdd:PRK06148   163 HAGRARDRLHFIDDPEDRALVERFLARFERNVAPRLAALPAQVIHNDANDYNILVDADdgERISGLIDFGDAVHAPRICE 242
                          250       260       270       280       290       300       310       320
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2183801873  246 LATALAYQLGQGDDLFAAVLPFIQAYHARLPLTDREFALLPTLIACRLALTILIPQRRAVLYPQNrDYLLRNLPAAWRSL 325
Cdd:PRK06148   243 VAIAAAYAILDHPDPIGAAAALVAGYHAVYPLQAQELDLLFDLIRMRLAVSVTNSASRREQTPDN-PYLAISEAPAWRLL 321
                          330
                   ....*....|....*....
gi 2183801873  326 AQLMPIPFTQISNLFRHAC 344
Cdd:PRK06148   322 ERLDAMNPRLATARLRKAC 340
 
Name Accession Description Interval E-value
PRK06148 PRK06148
hypothetical protein; Provisional
11-344 4.32e-89

hypothetical protein; Provisional


Pssm-ID: 180426 [Multi-domain]  Cd Length: 1013  Bit Score: 288.08  E-value: 4.32e-89
                           10        20        30        40        50        60        70        80
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2183801873   11 LTSDAPQVSLPQVQQIAAELYGLQGTPSGLAGERDSNFRLLTANNQGYMLRFINAAEQPAEMAFQSAMLAHIARQDSTLP 90
Cdd:PRK06148     4 LSHPAPEFTTKDAEALLAQHFGISATATPLDGERDLNFRLTTDDGADYILKIVNPSEPRVESDFQTAALDHLAAVAPDLP 83
                           90       100       110       120       130       140       150       160
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2183801873   91 VPRVVTSLQGETTP--HYPMGEQRLtLRMVTYLPGTPQV-MMPRTTALMRNLGDTLARLDLALSNFAHPGADRSLLWNLS 167
Cdd:PRK06148    84 VPRLIPSLSGASLAsaQDPDGEPRL-LRLLSWLPGTPLAeAAPRTEALLDNLGRALGRLDRALQGFMHPGALRDLDWDLR 162
                          170       180       190       200       210       220       230       240
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2183801873  168 EMPQMASWIAHLADPAQREAVATVLARYQQDVAPQLSQLRRQVIHNDLNPHNVLVTAE--HQVAGIIDFGDALQAPLINE 245
Cdd:PRK06148   163 HAGRARDRLHFIDDPEDRALVERFLARFERNVAPRLAALPAQVIHNDANDYNILVDADdgERISGLIDFGDAVHAPRICE 242
                          250       260       270       280       290       300       310       320
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2183801873  246 LATALAYQLGQGDDLFAAVLPFIQAYHARLPLTDREFALLPTLIACRLALTILIPQRRAVLYPQNrDYLLRNLPAAWRSL 325
Cdd:PRK06148   243 VAIAAAYAILDHPDPIGAAAALVAGYHAVYPLQAQELDLLFDLIRMRLAVSVTNSASRREQTPDN-PYLAISEAPAWRLL 321
                          330
                   ....*....|....*....
gi 2183801873  326 AQLMPIPFTQISNLFRHAC 344
Cdd:PRK06148   322 ERLDAMNPRLATARLRKAC 340
SrkA COG2334
Ser/Thr protein kinase RdoA involved in Cpx stress response, MazF antagonist [Signal ...
27-327 2.41e-61

Ser/Thr protein kinase RdoA involved in Cpx stress response, MazF antagonist [Signal transduction mechanisms]; Ser/Thr protein kinase RdoA involved in Cpx stress response, MazF antagonist is part of the Pathway/BioSystem: Threonine biosynthesis


Pssm-ID: 441905 [Multi-domain]  Cd Length: 297  Bit Score: 198.23  E-value: 2.41e-61
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2183801873  27 AAELYGL--QGTPSGLAGERDSNFRLLTANNQGYMLRFINAAE-QPAEMAFQSAMLAHIARQDstLPVPRVVTSLQGETT 103
Cdd:COG2334     6 ALERYGLgpLSSLKPLNSGENRNYRVETEDGRRYVLKLYRPGRwSPEEIPFELALLAHLAAAG--LPVPAPVPTRDGETL 83
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2183801873 104 PHYpmgeQRLTLRMVTYLPGTPqvMMPRTTALMRNLGDTLARLDLALSNFAHPGAdRSLLWNLSEMPQMASwiAHLADPA 183
Cdd:COG2334    84 LEL----EGRPAALFPFLPGRS--PEEPSPEQLEELGRLLARLHRALADFPRPNA-RDLAWWDELLERLLG--PLLPDPE 154
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2183801873 184 QREAVATVLARYQQDVAPQLSQLRRQVIHNDLNPHNVLVTAEHqVAGIIDFGDALQAPLINELATALAYQLGQGDDLfAA 263
Cdd:COG2334   155 DRALLEELLDRLEARLAPLLGALPRGVIHGDLHPDNVLFDGDG-VSGLIDFDDAGYGPRLYDLAIALNGWADGPLDP-AR 232
                         250       260       270       280       290       300
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*..
gi 2183801873 264 VLPFIQAYHARLPLTDREFALLPTLI---ACRLALTILipQRRAVLYPQNRDYLLRNLPAAWRSLAQ 327
Cdd:COG2334   233 LAALLEGYRAVRPLTEAELAALPPLLrlrALRFLAWRL--RRVRAKDPAFERYLRRQIALAWAALEA 297
HomoserineK_II cd05153
Type II Homoserine Kinase; This subfamily is composed of unusual homoserine kinases, from a ...
22-328 5.62e-42

Type II Homoserine Kinase; This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a Protein Kinase fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. The Type II homoserine kinase subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K).


Pssm-ID: 270702 [Multi-domain]  Cd Length: 300  Bit Score: 148.18  E-value: 5.62e-42
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2183801873  22 QVQQIAA-----ELYGLQGTPSGLAgerDSNFRLLTANNQgYMLRFINAAEQPAEMAFQSAMLAHIARQDstLPVPRVVT 96
Cdd:cd05153     3 ELAEFLAhydlgELLSFEGIAAGIE---NTNYFVTTTDGR-YVLTLFEKRRSAAELPFELELLDHLAQAG--LPVPRPLA 76
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2183801873  97 SLQGETTPHYpmGEQRLTLrmVTYLPGTPQVmmPRTTALMRNLGDTLARLDLALSNFAHPGA-DRSLLWNLSEMPQMASw 175
Cdd:cd05153    77 DKDGELLGEL--NGKPAAL--FPFLPGESLT--TPTPEQCRAIGAALARLHLALAGFPPPRPnPRGLAWWKPLAERLKA- 149
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2183801873 176 IAHLADPAQREAVATVLARYQqdvAPQLSQLRRQVIHNDLNPHNVLVTAEhQVAGIIDFGDALQAPLINELATALAYQLG 255
Cdd:cd05153   150 RLDLLAADDRALLEDELARLQ---ALAPSDLPRGVIHADLFRDNVLFDGD-RLSGIIDFYDACYDPLLYDLAIALNDWCF 225
                         250       260       270       280       290       300       310
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*
gi 2183801873 256 QGDDLFAAVL--PFIQAYHARLPLTDREFALLPTLIACRLALTILIPQRRAVLYPQNRDYLLRNLPAAWRSLAQL 328
Cdd:cd05153   226 DDDGKLDPERakALLAGYQSVRPLTEEEKAALPLLLRAAALRFWLSRLYDFHLPREGALVTPKDPDEFLRRLRQR 300
APH pfam01636
Phosphotransferase enzyme family; This family consists of bacterial antibiotic resistance ...
41-282 2.18e-22

Phosphotransferase enzyme family; This family consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include: aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation. This family also includes homoserine kinase. This family is related to fructosamine kinase pfam03881.


Pssm-ID: 426359 [Multi-domain]  Cd Length: 239  Bit Score: 94.10  E-value: 2.18e-22
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2183801873  41 AGERDSNFRLLTANnQGYMLRFINAAEQPAEMAFQSAMLAHIARQDSTlPVPRVVTSLQGETtphypmgEQRLTLRMVTY 120
Cdd:pfam01636   7 SGASNRTYLVTTGD-GRYVLRLPPPGRAAEELRRELALLRHLAAAGVP-PVPRVLAGCTDAE-------LLGLPFLLMEY 77
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2183801873 121 LPGTP--QVMMPRTT-ALMRNLGDTLARLDLALSNFAhpGADRSLLWNLSEMPQMASWIAHLADPAQREAVATVLARYQQ 197
Cdd:pfam01636  78 LPGEVlaRPLLPEERgALLEALGRALARLHAVDPAAL--PLAGRLARLLELLRQLEAALARLLAAELLDRLEELEERLLA 155
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2183801873 198 DVAPQL-SQLRRQVIHNDLNPHNVLVTAEHQVAGIIDFGDALQAPLINELATALAYQLGQGDDLFAAvlPFIQAYHARLP 276
Cdd:pfam01636 156 ALLALLpAELPPVLVHGDLHPGNLLVDPGGRVSGVIDFEDAGLGDPAYDLAILLNSWGRELGAELLA--AYLAAYGAFGY 233

                  ....*.
gi 2183801873 277 LTDREF 282
Cdd:pfam01636 234 ARLREL 239
 
Name Accession Description Interval E-value
PRK06148 PRK06148
hypothetical protein; Provisional
11-344 4.32e-89

hypothetical protein; Provisional


Pssm-ID: 180426 [Multi-domain]  Cd Length: 1013  Bit Score: 288.08  E-value: 4.32e-89
                           10        20        30        40        50        60        70        80
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2183801873   11 LTSDAPQVSLPQVQQIAAELYGLQGTPSGLAGERDSNFRLLTANNQGYMLRFINAAEQPAEMAFQSAMLAHIARQDSTLP 90
Cdd:PRK06148     4 LSHPAPEFTTKDAEALLAQHFGISATATPLDGERDLNFRLTTDDGADYILKIVNPSEPRVESDFQTAALDHLAAVAPDLP 83
                           90       100       110       120       130       140       150       160
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2183801873   91 VPRVVTSLQGETTP--HYPMGEQRLtLRMVTYLPGTPQV-MMPRTTALMRNLGDTLARLDLALSNFAHPGADRSLLWNLS 167
Cdd:PRK06148    84 VPRLIPSLSGASLAsaQDPDGEPRL-LRLLSWLPGTPLAeAAPRTEALLDNLGRALGRLDRALQGFMHPGALRDLDWDLR 162
                          170       180       190       200       210       220       230       240
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2183801873  168 EMPQMASWIAHLADPAQREAVATVLARYQQDVAPQLSQLRRQVIHNDLNPHNVLVTAE--HQVAGIIDFGDALQAPLINE 245
Cdd:PRK06148   163 HAGRARDRLHFIDDPEDRALVERFLARFERNVAPRLAALPAQVIHNDANDYNILVDADdgERISGLIDFGDAVHAPRICE 242
                          250       260       270       280       290       300       310       320
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2183801873  246 LATALAYQLGQGDDLFAAVLPFIQAYHARLPLTDREFALLPTLIACRLALTILIPQRRAVLYPQNrDYLLRNLPAAWRSL 325
Cdd:PRK06148   243 VAIAAAYAILDHPDPIGAAAALVAGYHAVYPLQAQELDLLFDLIRMRLAVSVTNSASRREQTPDN-PYLAISEAPAWRLL 321
                          330
                   ....*....|....*....
gi 2183801873  326 AQLMPIPFTQISNLFRHAC 344
Cdd:PRK06148   322 ERLDAMNPRLATARLRKAC 340
SrkA COG2334
Ser/Thr protein kinase RdoA involved in Cpx stress response, MazF antagonist [Signal ...
27-327 2.41e-61

Ser/Thr protein kinase RdoA involved in Cpx stress response, MazF antagonist [Signal transduction mechanisms]; Ser/Thr protein kinase RdoA involved in Cpx stress response, MazF antagonist is part of the Pathway/BioSystem: Threonine biosynthesis


Pssm-ID: 441905 [Multi-domain]  Cd Length: 297  Bit Score: 198.23  E-value: 2.41e-61
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2183801873  27 AAELYGL--QGTPSGLAGERDSNFRLLTANNQGYMLRFINAAE-QPAEMAFQSAMLAHIARQDstLPVPRVVTSLQGETT 103
Cdd:COG2334     6 ALERYGLgpLSSLKPLNSGENRNYRVETEDGRRYVLKLYRPGRwSPEEIPFELALLAHLAAAG--LPVPAPVPTRDGETL 83
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2183801873 104 PHYpmgeQRLTLRMVTYLPGTPqvMMPRTTALMRNLGDTLARLDLALSNFAHPGAdRSLLWNLSEMPQMASwiAHLADPA 183
Cdd:COG2334    84 LEL----EGRPAALFPFLPGRS--PEEPSPEQLEELGRLLARLHRALADFPRPNA-RDLAWWDELLERLLG--PLLPDPE 154
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2183801873 184 QREAVATVLARYQQDVAPQLSQLRRQVIHNDLNPHNVLVTAEHqVAGIIDFGDALQAPLINELATALAYQLGQGDDLfAA 263
Cdd:COG2334   155 DRALLEELLDRLEARLAPLLGALPRGVIHGDLHPDNVLFDGDG-VSGLIDFDDAGYGPRLYDLAIALNGWADGPLDP-AR 232
                         250       260       270       280       290       300
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*..
gi 2183801873 264 VLPFIQAYHARLPLTDREFALLPTLI---ACRLALTILipQRRAVLYPQNRDYLLRNLPAAWRSLAQ 327
Cdd:COG2334   233 LAALLEGYRAVRPLTEAELAALPPLLrlrALRFLAWRL--RRVRAKDPAFERYLRRQIALAWAALEA 297
PRK06149 PRK06149
aminotransferase;
15-344 1.13e-56

aminotransferase;


Pssm-ID: 235716 [Multi-domain]  Cd Length: 972  Bit Score: 198.30  E-value: 1.13e-56
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2183801873  15 APQVSLPQVQQIAAELYGLQGTPSGLAGERDSNFRLLTANNQgYMLRFINAAEQPAEMAFQSAMLAHIARQDSTLPVPRV 94
Cdd:PRK06149   14 APDVSEAQAERILAEHYGLSGTLTELGSQQDRNFRVDSDGGR-FVLKICHAAYAAVELEAQHAALRHLAEREPALRVPVV 92
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2183801873  95 VTSLQGETTPHYPMGEQRLTLRMVTYLPGTPQVMMPR-TTALMRNLGDTLARLDLALSNFAHPGADRSLLWNLSE-MPQM 172
Cdd:PRK06149   93 IPALDGEELLTLDVRGQGLRVRLLDYLPGQPLTRLGHlAPASVAGLGALCARVARALADFDHPGLDRTLQWDLRHaGPVV 172
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2183801873 173 ASWIAHLADPAQREAVATVLARYQQDVAPQLSQLRRQVIHNDLNPHNVLVT--AEHQVA--GIIDFGDALQAPLINELAT 248
Cdd:PRK06149  173 AHLLSHITDPAQRARIAEATRDAARRLQPLAPALPLQAVHLDITDDNVVGSrdADGRWQpdGVIDFGDLVRTWRVADLAV 252
                         250       260       270       280       290       300       310       320
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2183801873 249 ALAYQLGQGDDLFAAVLPFIQAYHARLPLTDREFALLPTLIACRLALTILIPQRRAVLYPQNrDYLLRNLPAAWRSLAQL 328
Cdd:PRK06149  253 TCASLLHHAGGDPFSILPAVRAYHAVRPLSEAELKALWPLVVARAAVLVASSEQQLAVDPDN-AYVRDNLAHEWEIFDVA 331
                         330
                  ....*....|....*.
gi 2183801873 329 MPIPFTQISNLFRHAC 344
Cdd:PRK06149  332 TSVPFALMEAAILAAL 347
HomoserineK_II cd05153
Type II Homoserine Kinase; This subfamily is composed of unusual homoserine kinases, from a ...
22-328 5.62e-42

Type II Homoserine Kinase; This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a Protein Kinase fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. The Type II homoserine kinase subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K).


Pssm-ID: 270702 [Multi-domain]  Cd Length: 300  Bit Score: 148.18  E-value: 5.62e-42
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2183801873  22 QVQQIAA-----ELYGLQGTPSGLAgerDSNFRLLTANNQgYMLRFINAAEQPAEMAFQSAMLAHIARQDstLPVPRVVT 96
Cdd:cd05153     3 ELAEFLAhydlgELLSFEGIAAGIE---NTNYFVTTTDGR-YVLTLFEKRRSAAELPFELELLDHLAQAG--LPVPRPLA 76
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2183801873  97 SLQGETTPHYpmGEQRLTLrmVTYLPGTPQVmmPRTTALMRNLGDTLARLDLALSNFAHPGA-DRSLLWNLSEMPQMASw 175
Cdd:cd05153    77 DKDGELLGEL--NGKPAAL--FPFLPGESLT--TPTPEQCRAIGAALARLHLALAGFPPPRPnPRGLAWWKPLAERLKA- 149
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2183801873 176 IAHLADPAQREAVATVLARYQqdvAPQLSQLRRQVIHNDLNPHNVLVTAEhQVAGIIDFGDALQAPLINELATALAYQLG 255
Cdd:cd05153   150 RLDLLAADDRALLEDELARLQ---ALAPSDLPRGVIHADLFRDNVLFDGD-RLSGIIDFYDACYDPLLYDLAIALNDWCF 225
                         250       260       270       280       290       300       310
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*
gi 2183801873 256 QGDDLFAAVL--PFIQAYHARLPLTDREFALLPTLIACRLALTILIPQRRAVLYPQNRDYLLRNLPAAWRSLAQL 328
Cdd:cd05153   226 DDDGKLDPERakALLAGYQSVRPLTEEEKAALPLLLRAAALRFWLSRLYDFHLPREGALVTPKDPDEFLRRLRQR 300
APH pfam01636
Phosphotransferase enzyme family; This family consists of bacterial antibiotic resistance ...
41-282 2.18e-22

Phosphotransferase enzyme family; This family consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include: aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation. This family also includes homoserine kinase. This family is related to fructosamine kinase pfam03881.


Pssm-ID: 426359 [Multi-domain]  Cd Length: 239  Bit Score: 94.10  E-value: 2.18e-22
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2183801873  41 AGERDSNFRLLTANnQGYMLRFINAAEQPAEMAFQSAMLAHIARQDSTlPVPRVVTSLQGETtphypmgEQRLTLRMVTY 120
Cdd:pfam01636   7 SGASNRTYLVTTGD-GRYVLRLPPPGRAAEELRRELALLRHLAAAGVP-PVPRVLAGCTDAE-------LLGLPFLLMEY 77
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2183801873 121 LPGTP--QVMMPRTT-ALMRNLGDTLARLDLALSNFAhpGADRSLLWNLSEMPQMASWIAHLADPAQREAVATVLARYQQ 197
Cdd:pfam01636  78 LPGEVlaRPLLPEERgALLEALGRALARLHAVDPAAL--PLAGRLARLLELLRQLEAALARLLAAELLDRLEELEERLLA 155
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2183801873 198 DVAPQL-SQLRRQVIHNDLNPHNVLVTAEHQVAGIIDFGDALQAPLINELATALAYQLGQGDDLFAAvlPFIQAYHARLP 276
Cdd:pfam01636 156 ALLALLpAELPPVLVHGDLHPGNLLVDPGGRVSGVIDFEDAGLGDPAYDLAILLNSWGRELGAELLA--AYLAAYGAFGY 233

                  ....*.
gi 2183801873 277 LTDREF 282
Cdd:pfam01636 234 ARLREL 239
YcbJ COG3173
Predicted kinase, aminoglycoside phosphotransferase (APT) family [General function prediction ...
70-274 1.44e-12

Predicted kinase, aminoglycoside phosphotransferase (APT) family [General function prediction only];


Pssm-ID: 442406 [Multi-domain]  Cd Length: 284  Bit Score: 67.06  E-value: 1.44e-12
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2183801873  70 AEMAFQSAMLAHIARQdSTLPVPRVVtsLQGETTPHYPMGeqrlTLRMvTYLPGT------PQVMMPRTTALMRNLGDTL 143
Cdd:COG3173    58 HDVRREARVLRALAPR-LGVPVPRPL--ALGEDGEVIGAP----FYVM-EWVEGEtledalPDLSPAERRALARALGEFL 129
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2183801873 144 ARL------DLALSNFAHPGADRsllwnlsempQMASWIAHLAD-PAQREAVATVLARYQQDVAPQLSQLRRQV-IHNDL 215
Cdd:COG3173   130 AALhavdpaAAGLADGRPEGLER----------QLARWRAQLRRaLARTDDLPALRERLAAWLAANLPEWGPPVlVHGDL 199
                         170       180       190       200       210       220
                  ....*....|....*....|....*....|....*....|....*....|....*....|
gi 2183801873 216 NPHNVLVTAEH-QVAGIIDFGDALQAPLINELATALAYqLGQGDDLFAAVLPFIQAYHAR 274
Cdd:COG3173   200 RPGNLLVDPDDgRLTAVIDWELATLGDPAADLAYLLLY-WRLPDDLLGPRAAFLAAYEEA 258
PRK05231 PRK05231
homoserine kinase; Provisional
17-296 3.13e-11

homoserine kinase; Provisional


Pssm-ID: 235369 [Multi-domain]  Cd Length: 319  Bit Score: 63.66  E-value: 3.13e-11
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2183801873  17 QVSLPQVQQIAA-----ELYGLQGTPSGLageRDSNFrLLTANNQGYML----RfINAAEQPaemaFQSAMLAHIARQDs 87
Cdd:PRK05231    6 DVSDDELAAFLApydlgELLSLKGIAEGI---ENSNF-FLTTTQGEYVLtlfeR-LTAEDLP----FFLGLMQHLAARG- 75
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2183801873  88 tLPVPRVVTSLQGETtphypmgeqrltLRM--------VTYLPGtpqVMMPRTTALM-RNLGDTLARLDLALSNFAHPGA 158
Cdd:PRK05231   76 -VPVPAPVARRDGAA------------LGElagkpaaiVTFLEG---KWPRAPTAAHcAEVGEMLARMHLAGRDFPLERP 139
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2183801873 159 -DRSLLWNLSEMPQMASwiaHLADPAQ---REAVATVLARYQQDVAPQLSqlrRQVIHNDLNPHNVLVTAEHqVAGIIDF 234
Cdd:PRK05231  140 nLRGLAWWRELAPRLLP---FLADEQAallEAELAAQLAFLASAAWPALP---RGVIHADLFRDNVLFEGDR-LSGFIDF 212
                         250       260       270       280       290       300
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*...
gi 2183801873 235 GDALQAPLINELATAL---AYQLGQGDDLfAAVLPFIQAYHARLPLTDREFALLPTLI---ACRLALT 296
Cdd:PRK05231  213 YFACNDKLLYDVAITLndwCFEADGSLDA-TKARALLAAYQSVRPLTAAERAALPVMLrgaALRFWLS 279
APH_ChoK_like_1 cd05155
Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase and ...
79-236 4.77e-06

Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase and Choline kinase; This subfamily is composed of uncharacterized bacterial proteins with similarity to APH and ChoK. Other APH/ChoK-like proteins include ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). These proteins catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. The APH/ChoK-like subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K).


Pssm-ID: 270704 [Multi-domain]  Cd Length: 234  Bit Score: 47.23  E-value: 4.77e-06
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2183801873  79 LAHIARQdSTLPVPRVVTslQGETTPHYPMgeqrlTLRMVTYLPGTPQVMMPRTTalMRNLGDTLARLDLALSNFA---- 154
Cdd:cd05155    42 LPRLAPR-LPLPVPVPLA--LGKPGAGYPW-----PWSVYRWLEGETAADAPLAD--PAAAAEDLARFLAALHAIDpagp 111
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2183801873 155 ------HPGADRSLlwnlsempQMASWIAHLADPAQREAVATVLARYQQDVAPQLSQLRRQVIHNDLNPHNVLVtAEHQV 228
Cdd:cd05155   112 pnpgrgNPLRGRDL--------AVRDAEEALAALAGLLDVAAARALWERALAAPAWAGPPVWLHGDLHPGNLLV-RDGRL 182

                  ....*...
gi 2183801873 229 AGIIDFGD 236
Cdd:cd05155   183 SAVIDFGD 190
APH_ChoK_like cd05120
Aminoglycoside 3'-phosphotransferase and Choline Kinase family; This family is composed of APH, ...
178-251 1.07e-05

Aminoglycoside 3'-phosphotransferase and Choline Kinase family; This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K).


Pssm-ID: 270690 [Multi-domain]  Cd Length: 158  Bit Score: 44.99  E-value: 1.07e-05
                          10        20        30        40        50        60        70
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*...
gi 2183801873 178 HLADPAQREAVAtvlaryqQDVAPQLSQLRRQ----VIHNDLNPHNVLVTAEHQVAGIIDFGDALQAPLINELATALA 251
Cdd:cd05120    84 PRLSEEEKEKIA-------DQLAEILAALHRIdssvLTHGDLHPGNILVKPDGKLSGIIDWEFAGYGPPAFDYAAALR 154
ACAD10_11_N-like cd05154
N-terminal domain of Acyl-CoA dehydrogenase (ACAD) 10 and 11, and similar proteins; This ...
86-274 4.10e-05

N-terminal domain of Acyl-CoA dehydrogenase (ACAD) 10 and 11, and similar proteins; This subfamily is composed of the N-terminal domains of vertebrate ACAD10 and ACAD11, and similar uncharacterized bacterial and eukaryotic proteins. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 are both significantly expressed in human brain tissues. They contain a long N-terminal domain with similarity to phosphotransferases with a Protein Kinase fold, which is absent in other ACADs. They may exhibit multiple functions in acyl-CoA oxidation pathways. ACAD11 utilizes substrates with carbon chain lengths of 20 to 26, with optimal activity towards C22CoA. ACAD10 may be associated with an increased risk in type II diabetes. The ACAD10/11-like subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K).


Pssm-ID: 270703 [Multi-domain]  Cd Length: 254  Bit Score: 44.53  E-value: 4.10e-05
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2183801873  86 DSTLPVPRVVTSLQGET---TPHYPMGeqrltlrmvtYLPGT--PQVMMPRT------TALMRNLGDTLARL------DL 148
Cdd:cd05154    57 GTGVPVPRVLALCEDPSvlgAPFYVME----------RVDGRvlPDPLPRPDlspeerRALARSLVDALAALhsvdpaAL 126
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2183801873 149 ALSNFAHPG--ADRsllwnlsempQMASWIAHLADPAQREA-VATVLARYQQDVAPQLSQLRrqVIHNDLNPHNVLVTAE 225
Cdd:cd05154   127 GLADLGRPEgyLER----------QVDRWRRQLEAAATDPPpALEEALRWLRANLPADGRPV--LVHGDFRLGNLLFDPD 194
                         170       180       190       200       210       220
                  ....*....|....*....|....*....|....*....|....*....|....*....|....
gi 2183801873 226 HQVAGIID-----FGDALQaplinELATALAYQLGQGDDLFAAVLP----------FIQAYHAR 274
Cdd:cd05154   195 GRVTAVLDwelatLGDPLE-----DLAWLLARWWRPGDPPGLAAPTrlpgfpsreeLLARYEEA 253
CotS COG0510
Thiamine kinase or a related kinase [Coenzyme transport and metabolism];
180-318 2.94e-04

Thiamine kinase or a related kinase [Coenzyme transport and metabolism];


Pssm-ID: 440276 [Multi-domain]  Cd Length: 156  Bit Score: 40.92  E-value: 2.94e-04
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2183801873 180 ADPAQREAVATVLARYQQDVAPQlsQLRRQVIHNDLNPHNVLVTAEHQVAgIIDFGDALQAPLINELAtALAYQLGQGDD 259
Cdd:COG0510    23 LGPRDLPELLRRLEELERALAAR--PLPLVLCHGDLHPGNFLVTDDGRLY-LIDWEYAGLGDPAFDLA-ALLVEYGLSPE 98
                          90       100       110       120       130       140
                  ....*....|....*....|....*....|....*....|....*....|....*....|....
gi 2183801873 260 LFAAvlpFIQAYHARLPltdrEFALLPTLIACRLALTILIPQRRAVLYPQ-----NRDYLLRNL 318
Cdd:COG0510    99 QAEE---LLEAYGFGRP----TEELLRRLRAYRALADLLWALWALVRAAQeangdLLKYLLRRL 155
Bud32 COG3642
tRNA A-37 threonylcarbamoyl transferase component Bud32 [Translation, ribosomal structure and ...
197-279 1.37e-03

tRNA A-37 threonylcarbamoyl transferase component Bud32 [Translation, ribosomal structure and biogenesis]; tRNA A-37 threonylcarbamoyl transferase component Bud32 is part of the Pathway/BioSystem: tRNA modification


Pssm-ID: 442859 [Multi-domain]  Cd Length: 159  Bit Score: 38.79  E-value: 1.37e-03
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2183801873 197 QDVAPQLSQL-RRQVIHNDLNPHNVLVTAEHQVagIIDFGDALQAPLINELATALA--------YQLGQGDDLFAAvlpF 267
Cdd:COG3642    58 RELGRLLARLhRAGIVHGDLTTSNILVDDGGVY--LIDFGLARYSDPLEDKAVDLAvlkrslesTHPDPAEELWEA---F 132
                          90
                  ....*....|..
gi 2183801873 268 IQAYHARLPLTD 279
Cdd:COG3642   133 LEGYREVGPAEE 144
RIO2 COG0478
RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction ...
207-234 6.47e-03

RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms];


Pssm-ID: 440246 [Multi-domain]  Cd Length: 183  Bit Score: 37.19  E-value: 6.47e-03
                          10        20
                  ....*....|....*....|....*...
gi 2183801873 207 RRQVIHNDLNPHNVLVTAEHQVAgIIDF 234
Cdd:COG0478   108 DAGIVHADLSEYNILVDDDGGVW-IIDW 134
STKc_PRP4 cd14135
Catalytic domain of the Serine/Threonine Kinase, Pre-mRNA-Processing factor 4; STKs catalyze ...
203-240 8.12e-03

Catalytic domain of the Serine/Threonine Kinase, Pre-mRNA-Processing factor 4; STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. PRP4 phosphorylates a number of factors involved in the formation of active spliceosomes, which catalyze pre-mRNA splicing. It phosphorylates PRP6 and PRP31, components of the U4/U6-U5 tri-small nuclear ribonucleoprotein (snRNP), during spliceosomal complex formation. In fission yeast, PRP4 phosphorylates the splicing factor PRP1 (U5-102 kD in mammals). Thus, PRP4 plays a key role in regulating spliceosome assembly and pre-mRNA splicing. It also plays an important role in mitosis by acting as a spindle assembly checkpoint kinase that is required for chromosome alignment and the recruitment of the checkpoint proteins MPS1, MAD1, and MAD2 at kinetochores. The PRP4 subfamily is part of a larger superfamily that includes the catalytic domains of other STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase.


Pssm-ID: 271037 [Multi-domain]  Cd Length: 318  Bit Score: 37.59  E-value: 8.12e-03
                          10        20        30
                  ....*....|....*....|....*....|....*....
gi 2183801873 203 LSQLRR-QVIHNDLNPHNVLVTAEHQVAGIIDFGDALQA 240
Cdd:cd14135   118 LKHLKKcNILHADIKPDNILVNEKKNTLKLCDFGSASDI 156
PKc cd00180
Catalytic domain of Protein Kinases; PKs catalyze the transfer of the gamma-phosphoryl group ...
207-237 9.60e-03

Catalytic domain of Protein Kinases; PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. PKs make up a large family of serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and more than 500 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase.


Pssm-ID: 270622 [Multi-domain]  Cd Length: 215  Bit Score: 36.86  E-value: 9.60e-03
                          10        20        30
                  ....*....|....*....|....*....|.
gi 2183801873 207 RRQVIHNDLNPHNVLVTAEHQVAgIIDFGDA 237
Cdd:cd00180   110 SNGIIHRDLKPENILLDSDGTVK-LADFGLA 139
 
Blast search parameters
Data Source: Precalculated data, version = cdd.v.3.21
Preset Options:Database: CDSEARCH/cdd   Low complexity filter: no  Composition Based Adjustment: yes   E-value threshold: 0.01

References:

  • Wang J et al. (2023), "The conserved domain database in 2023", Nucleic Acids Res.51(D)384-8.
  • Lu S et al. (2020), "The conserved domain database in 2020", Nucleic Acids Res.48(D)265-8.
  • Marchler-Bauer A et al. (2017), "CDD/SPARCLE: functional classification of proteins via subfamily domain architectures.", Nucleic Acids Res.45(D)200-3.
Help | Disclaimer | Write to the Help Desk
NCBI | NLM | NIH